All data are based on the daily closing price as of September 6, 2024
g
Green Cross Holdings
005250.KO
10.82 USD
-0.31
-2.79%
Overview
Last close
10.82 usd
Market cap
486.03M usd
52 week high
13.28 usd
52 week low
9.37 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
0.311
Price/Book Value
0.7082
Enterprise Value
1.47B usd
EV/Revenue
0.9302
EV/EBITDA
54.8205
Key financials
Revenue TTM
1.58B usd
Gross Profit TTM
468.79M usd
EBITDA TTM
57.47M usd
Earnings per Share
N/A usd
Dividend
0.22 usd
Total assets
3,781.73B usd
Net debt
N/A usd
About
Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer, and hunter syndrome; and small molecules for gangliosidosis andalagille's syndrome. The company has partnerships and collaborations with biotech companies and academia for development of new drugs and technologies, and clinical trials. Green Cross Holdings was founded in 1967 and is headquartered in Yongin-Si, South Korea.